EDGAR Sentinel

autonomous SEC filing research · runs daily on Google Cloud
LCID · Lucid Group, Inc.

10-Q filed 2026-08-04 period 2026-06-30

34 Distress
confidence high · source filing on SEC.gov ↗
  • Lucid recorded a net loss of $2.06B and negative operating cash flow of $2.41B for the first half of 2026, with gross margins remaining deeply negative at -105.3% due to high inventory write-downs of $299.7M in Q2.
  • To sustain operations, Lucid issued $550M of Series C Preferred Stock to Ayar in April 2026 and drew an additional $800M under its DDTL Credit Facility in July 2026, highlighting extreme dependence on its controlling shareholder.
  • Silvio Napoli was appointed CEO and Alexander De Bock as CFO amid a major restructuring (June 2026 Plan) that eliminated the COO role, reduced workforce (costing $34M), and targets $158M in annualized savings.

vs. prior filing (10-Q filed 2026-05-05)

FHS 30 → 34 (+4) · Distress -> Distress
Profitability +10Balance sheet +10Cash generation +5Risk flags +0Mgmt signal -10

Filing Health Score pillars

Profitability 25%
25
While revenue grew 56% YoY in Q2 2026, gross margins remain deeply negative at -105.3% due to high inventory write-downs of $299.7M and production levels remaining significantly below manufacturing capacity (MD&A Results of Operations).
Balance sheet 20%
35
Lucid's current ratio is tight at 1.14, and total debt of $3.25B significantly exceeds cash and short-term investments of $761.3M, while common shares outstanding diluted by approximately 20% in six months (Condensed Consolidated Balance Sheets).
Cash generation 20%
15
Cash burn is extremely high, with operating cash outflows of $2.41B exceeding the net loss of $2.06B for the first six months of 2026, compounded by $507M in capital expenditures (Condensed Consolidated Statements of Cash Flows).
Risk flags 20%
45
No going-concern qualification is present, but the company has an accumulated deficit of $17.7B and is highly dependent on its majority shareholder, Ayar (PIF), for survival and continuous capital injections (Note 1 & Note 15).
Mgmt signal 15%
55
Management is taking aggressive cost-cutting actions, including a workforce reduction plan to save $158M annually and identifying $1.4B in cash flow improvements, alongside major executive leadership changes (MD&A Recent Developments).

Key metrics (Six Months Ended June 30, 2026)

period: Six Months Ended June 30, 2026
total debt: $3,253,698 thousand
cash and equivalents: $732,601 thousand
shares outstanding: 394,070,176
revenue: $687,812 thousand
net income: $(2,063,195) thousand
operating cash flow: $(2,407,890) thousand

Gemma triage notes (pre-analysis, second opinion)

None for this filing.
Automated research summaries derived from SEC filings. Not investment advice.